14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CTRV
Delisted

ContraVir Pharmaceuticals Inc Stock Predictions

$1.23
+0 (+0%)
At Close: May 27, 2022
Currently predicting for Mon, 6 May 2024

CTRV Predictions History

4 years ago
Alex.TinyVillianaire.Goh.110165 predicted that CTRV for 2019-05-06 is going $0.145 (-1.29%)

Rank:

5 years ago
JS predicted that CTRV for 2019-05-06 is going $0.131 (-10.82%)

5 years ago
joe1234 predicted that CTRV for 2019-05-06 is going $0.170 (15.72%)

5 years ago
PumpTheseNumbers predicted that CTRV for 2019-05-02 is going $0.180 (7.14%)

5 years ago
NameNotImportant predicted that CTRV for 2019-04-29 is going $0.104 (-5.45%)

5 years ago
JS predicted that CTRV for 2019-04-26 is going $0.137 (24.55%)

5 years ago
PumpTheseNumbers predicted that CTRV for 2019-04-26 is going $0.144 (30.91%)

5 years ago
Alan.Cvz.109021 predicted that CTRV for 2019-04-26 is going $0.360 (213.04%)

Rank:

6 years ago
ladd.mccoy.19983 predicted that CTRV for 2018-02-15 is going $0.355 (39.22%)

Rank:

6 years ago
bbullish2 predicted that CTRV for 2018-02-15 is going $0.251 (-3.65%)

Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... CTRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT